Emergent BioSolutions Inc. is a global life sciences company that primarily focuses on the development, manufacturing, and distribution of a wide array of medical products. These products are designed to address public health threats including chemical and biological agents, and infectious diseases. As an important player in the health sector, the company is known for its specialized work in vaccines, antibody therapeutics, and medical devices. Notably, Emergent BioSolutions is a key supplier of biodefense solutions, including anthrax and smallpox vaccines, which are critical to national security programs. The company’s operations span pharmaceutical manufacturing, research, and development, and it works in partnership with both government and commercial entities. Headquartered in Gaithersburg, Maryland, Emergent BioSolutions plays a pivotal role in emergency preparedness, health security, and response solutions, underscoring its importance in global health initiatives and the broader pharmaceutical industry.